Cochlear Limited (CHEOY) Q3 2026 Sales/Trading Call Transcript
Cochlear shares crashed nearly 41% on Wednesday in a record daily fall, after the Australian hearing implants maker slashed its forecast for annual earnings, citing weak trading conditions and uncertainty stoked by the Middle East war.
Cochlear Limited (CHEOY) Q2 2026 Earnings Call Transcript
| Health Care Equipment & Supplies Industry | Healthcare Sector | Diggory William Howitt CEO | OTC PINK Exchange | 191459205 CUSIP |
| AU Country | 5,500 Employees | 20 Mar 2026 Last Dividend | - Last Split | - IPO Date |
Cochlear Limited, established in 1981 and headquartered in Sydney, Australia, is a global leader in providing implantable hearing solutions. It is dedicated to helping children and adults worldwide to overcome hearing loss through innovative technologies. The company takes pride in its extensive history of advancing the field of auditory health, offering a range of products that enhance the ability to hear and communicate effectively.